You are here: Simmaron ResearchPathogensViral Finding May Open Treatment Possibilities for 15-20K Chronic Fatigue Syndrome Patients in the U.S.Valganciclovir

Valganciclovir

August 1, 2013

0 Comments

valcyte molecule

Valganciclovir (Valcyte) is effective against HHV-6; (valaciyclovir) Valtrex is not

Print Friendly, PDF & Email

Donate Button

  • Get involved in our Spring fundraiser and you just may be selected to receive a gift basket with SRI swag, an Echo… ,
  • Our team is AMPed! We are already receiving amazing support from our online community. We are grateful for your co… ,
  • Did you know? Simmaron’s work with Ampligen® seeks to answer: who responds to the treatment, which biomarkers tra… ,